Insights & Discussion
Discover Related Insights
Consuming two SunGold kiwifruits daily over 12 weeks improved vitamin C status, reduced blood pressure, waist measurements and altered faecal microbiota composition in prediabetic individuals.
2018 Nutrients SunGold Kiwifruit Supplementation of Individuals with Prediabetes Alters Gut Microbiota and Improves Vitamin C Status, Anthropometric and Clinical Markers Wilson R, Willis J, Gearry R, Hughes A, Lawley B, Skidmore P, et al.
Randomised Controlled Trial Gut Microbiota High Blood Pressure Kiwifruit
Over a 12 week pilot intervention trial, people with prediabetes were observed after consuming two SunGold kiwifruits per day. Participants filled out a physical activity questionnaire and a three-day estimated food diary at both the commencement and end of the trial. Venous blood samples were collected at the start, in between (at 6 weeks) and at the end of the trial, to observe glycaemic indices, plasma vitamin C concentrations, hormones, lipid profiles and high-sensitivity C-reactive protein levels. Additionally, participants provided faecal samples at each visit for DNA extraction and subsequent amplification and sequencing of a region of the 16S ribosomal RNA gene to determine faecal microbiota composition.
The differences were then compared between week 12 and their baseline measurements revealing a significant increase in plasma vitamin C concentration. Further changes including significant reductions in both diastolic and systolic blood pressure as well as waist circumference and waist-to-hip ratio were recorded. Despite recording a slight drop in HbA1c levels and a minor increase in fasting glucose, the changes were small and not clinically significant. Moreover, the composition analysis of the faecal microbiota indicated an increase in the relative abundance of hitherto uncultivated, hence uncharacterised members of a particular bacterial family. These findings suggest that these unknown bacterial members could potentially have a functional relationship with the polysaccharides and polyphenols in kiwifruits.
Avocado, with its lipid-lowering, antihypertensive, antidiabetic, anti-obesity, and cardioprotective effects, can potentially manage metabolic syndrome more efficaciously than synthetic treatment options.
2017 Phytotherapy Research Effects of Avocado (Persea americana)on Metabolic Syndrome: A Comprehensive Systematic Review Tabeshpour J, Razavi BM, Hosseinzadeh H
Systematic Review Avocado Cardiovascular Disease High Blood Pressure
The methodology used in this research involved a systematic review of several studies investigating the pharmacological effects of avocado on different components of metabolic syndrome. This included studies on the lipid-lowering, antihypertensive, antidiabetic, anti-obesity, antithrombotic, antiatherosclerotic, and cardioprotective effects of avocado. Further, the review also encompassed researches based on the effects of avocado's various parts like the flesh, seed, peel, and leaves in metabolic syndrome.
Upon evaluation of collected studies, the researchers found that the avocado, a rich source of carotenoids, minerals, phenolics, vitamins, and fatty acids, demonstrates strong potential in managing metabolic syndrome. Its antidiabetic, antihypertensive, anti-obesity, lipid-lowering, and cardioprotective properties specifically align with the key risk factors of metabolic disease, including high blood sugar, dyslipidemia, hypertension, and obesity. These qualities suggest that avocado might present a more efficient and less adverse alternative to synthetic treatments.